Florian Krammer

63.4k total citations · 14 hit papers
368 papers, 22.9k citations indexed

About

Florian Krammer is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Florian Krammer has authored 368 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Epidemiology, 140 papers in Infectious Diseases and 137 papers in Immunology. Recurrent topics in Florian Krammer's work include Influenza Virus Research Studies (239 papers), Respiratory viral infections research (167 papers) and SARS-CoV-2 and COVID-19 Research (91 papers). Florian Krammer is often cited by papers focused on Influenza Virus Research Studies (239 papers), Respiratory viral infections research (167 papers) and SARS-CoV-2 and COVID-19 Research (91 papers). Florian Krammer collaborates with scholars based in United States, Austria and United Kingdom. Florian Krammer's co-authors include Peter Palese, Fatima Amanat, Adolfo Garcı́a-Sastre, Raffael Nachbagauer, Irina Margine, Gene S. Tan, Rong Hai, Viviana Simon, Patrick C. Wilson and Shirin Strohmeier and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Florian Krammer

343 papers receiving 22.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

2020 2.2k citations Florian Krammer et al. profile →
SARS-CoV-2 vaccines in development

2020 1.3k citations Florian Krammer Nature profile →
Influenza

2018 1.0k citations Florian Krammer, Peter Palese et al. profile →
SARS-CoV-2 Vaccines: Status Report

2020 789 citations Fatima Amanat, Florian Krammer profile →
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

2020 648 citations Ania Wajnberg, Fatima Amanat et al. profile →
The human antibody response to influenza A virus infection and vaccination

2019 484 citations Florian Krammer profile →
Advances in the development of influenza virus vaccines

2015 460 citations Florian Krammer, Peter Palese profile →
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

2017 387 citations Raffael Nachbagauer, Adolfo Garcı́a-Sastre et al. profile →
The first 12 months of COVID-19: a timeline of immunological insights

2021 255 citations Florian Krammer et al. profile →
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

2020 207 citations Florian Krammer, Peter Palese et al. profile →
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

2018 201 citations Meagan McMahon, Florian Krammer et al. profile →
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

2021 194 citations Florian Krammer et al. profile →
mRNA vaccines for infectious diseases — advances, challenges and opportunities

2024 67 citations Florian Krammer et al. profile →
Highly pathogenic avian influenza H5N1: history, current situation, and outlook

2025 20 citations Florian Krammer et al. Journal of Virology profile →

Peers

Countries citing papers authored by Florian Krammer

Since Specialization

Citations

This map shows the geographic impact of Florian Krammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Krammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Krammer more than expected).

Fields of papers citing papers by Florian Krammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Krammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Krammer. The network helps show where Florian Krammer may publish in the future.

Co-authorship network of co-authors of Florian Krammer

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Krammer. A scholar is included among the top collaborators of Florian Krammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Krammer. Florian Krammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination 2025 ·mBio ·Anass Abbad, (unknown), (unknown), Brian Monahan, Gagandeep Singh, Andrew Wilson, Stefan Slamanig, (unknown), Neko Lyttle, (unknown), Keith Farrugia, (unknown), Ana S. Gonzalez‐Reiche, (unknown), Weina Sun, Harm van Bakel, Viviana Simon, Florian Krammer	0
2	Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2 2024 ·Vaccine ·Erin Williams, (unknown), Juan Manuel Carreño, Florian Krammer, Michael E. Hoffer, Suresh Pallikkuth, Savita Pahwa	0
3	A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters 2024 ·Vaccine ·Irene Hoxie, (unknown), Jordan J. Clark, (unknown), Ben Francis, (unknown), John D. Campbell, Dihua Yu, Lizheng Guan, Chunyang Gu, Shufang Fan, S. Mark Tompkins, Gabriele Neumann, Yoshihiro Kawaoka, Florian Krammer	8
4	Enhancing NA immunogenicity through novel VLP designs. 2024 ·Vaccine ·(unknown), (unknown), Irene Hoxie, (unknown), (unknown), (unknown), Florian Krammer, Alois Jungbauer, Patrícia Pereira Aguilar, Miriam Klausberger, Reingard Grabherr	3
5	An ELISA‐Based Method to Measure Mucosal Antibody Responses Against SARS‐CoV‐2 in Human Saliva 2024 ·Current Protocols ·Disha Bhavsar, Kaori Sano, Gagandeep Singh, Florian Krammer	0
6	Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products 2023 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Kaori Sano, Brandon Lam, Katharina Röltgen, Disha Bhavsar, Gagandeep Singh, (unknown), Stephanie Jeong, (unknown), Hsi-en Ho, Scott D. Boyd, Florian Krammer, Charlotte Cunningham‐Rundles	8
7	Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice 2022 ·Human Vaccines & Immunotherapeutics ·(unknown), Caroline Gravel, Greg Harris, Anwar M. Hashem, (unknown), David Safronetz, Gary Van Domselaar, Florian Krammer, Simon Sauvé, Michael Rosu‐Myles, Lisheng Wang, Wangxue Chen, Xuguang Li	5
8	Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity 2022 ·The Journal of Infectious Diseases ·Annika Rössler, Janine Kimpel, (unknown), Silke Huber, Dorotheé von Laer, Wegene Borena, Reinhard Würzner, (unknown), David Bante, Barbara Falkensammer, (unknown), Florian Krammer, Peter Pichler, Ursula Wiedermann, Daniel N. Rainer, (unknown), August Zabernigg	1
9	FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection 2021 ·The Journal of Immunology ·(unknown), Weizhong Li, (unknown), Senthilkumar Palaniyandi, (unknown), (unknown), Gefei Wang, Florian Krammer, Meiqing Shi, Wenbin Tuo, C. David Pauza, Xiaoping Zhu	12
10	Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response 2021 ·npj Vaccines ·Anders Madsen, Åsne Jul‐Larsen, Mai-Chi Trieu, Florian Krammer, Rebecca Jane Cox	5
11	Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase 2021 ·mSphere ·Ericka Kirkpatrick Roubidoux, Meagan McMahon, Juan Manuel Carreño, Christina Capuano, Kaijun Jiang, Viviana Simon, Harm van Bakel, Patrick C. Wilson, Florian Krammer	18
12	Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City 2020 ·Nature ·Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, Matthew M. Hernandez, Shelcie Fabre, Fatima Amanat, Su Hui Catherine Teo, Guha Asthagiri Arunkumar, Meagan McMahon, Christina Capuano, Kathryn Twyman, Jeffrey S. Jhang, Michael D. Nowak, Viviana Simon, Emilia Mia Sordillo, Harm van Bakel, Florian Krammer	72
13	Neutralizing Antibody Responses in COVID-19 Convalescent Sera 2020 ·The Journal of Infectious Diseases ·William T. Lee, Roxie C. Girardin, Alan P. Dupuis, Karen E. Kulas, Anne F. Payne, Susan J. Wong, Suzanne Arinsburg, Freddy T. Nguyen, Damodara Rao Mendu, Adolfo Firpo‐Betancourt, Jeffrey S. Jhang, Ania Wajnberg, Florian Krammer, Carlos Cordon‐Cardo, Sherlita Amler, Marisa A. Montecalvo, Brad Hutton, Jill Taylor, Kathleen A. McDonough	62
14	H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model 2020 ·mBio ·Juan Manuel Carreño, Shirin Strohmeier, Ericka Kirkpatrick Roubidoux, Rong Hai, Peter Palese, Florian Krammer	12
15	No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination 2019 ·Vaccine X ·Anders Madsen, (unknown), Sarah M. Tete, Fan Zhou, Florian Krammer, Rebecca Jane Cox, Åsne Jul‐Larsen	6
16	Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults 2019 ·Clinical Infectious Diseases ·Hannah E. Maier, Raffael Nachbagauer, Guillermina Kuan, Sophia Ng, Roger López, Nery Sánchez, Daniel Stadlbauer, Lionel Gresh, Amy Schiller, Arvind Rajabhathor, Sergio Ojeda, (unknown), Fatima Amanat, Ángel Balmaseda, Florian Krammer, Aubree Gordon	64
17	Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge 2018 ·Journal of Virology ·Raffael Nachbagauer, D.A. Shore, Hua Yang, Scott K. Johnson, Jon D. Gabbard, S. Mark Tompkins, Jens Wrammert, Patrick C. Wilson, James Stevens, Rafi Ahmed, Florian Krammer, (unknown)	24
18	A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies 2018 ·Vaccines ·Sun-Young Sunwoo, Michael Schotsaert, Igor Morozov, A. Sally Davis, Yuhao Li, Jinhwa Lee, Chester D. McDowell, Philip Meade, Raffael Nachbagauer, Adolfo Garcı́a-Sastre, Wenjun Ma, Florian Krammer, Jüergen A. Richt	16
19	Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice 2018 ·Journal of Virology ·Felix Broecker, Sean Liu, Weina Sun, Florian Krammer, Viviana Simon, Peter Palese	34
20	NS1-Truncated Live Attenuated Virus Vaccine Provides Robust Protection to Aged Mice from Viral Challenge 2012 ·Journal of Virology ·Natalie Pica, Ryan A. Langlois, Florian Krammer, Irina Margine, Peter Palese	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact